DEFA14A 1 lmdt_defa14a.htm MEDTRONIC PLC - DEFA14A MEDTRONIC PLC - DEFA14A

UNITED STATES

 

SECURITIES AND EXCHANGE COMMISSION

 

Washington, D.C. 20549

 

SCHEDULE 14A

 

Proxy Statement Pursuant to Section 14(a) of the Securities

Exchange Act of 1934 (Amendment No. )

 

 Filed by the Registrant  Filed by a Party other than the Registrant

 

Check the appropriate box:
Preliminary Proxy Statement
CONFIDENTIAL, FOR USE OF THE COMMISSION ONLY (AS PERMITTED BY RULE 14a-6(e)(2))
Definitive Proxy Statement
Definitive Additional Materials
Soliciting Material Pursuant to §240.14a-12

 

(Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

 

Payment of Filing Fee (Check the appropriate box):
No fee required.
Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.
(1) Title of each class of securities to which transaction applies:
(2) Aggregate number of securities to which transaction applies:
(3) Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11
(set forth the amount on which the filing fee is calculated and state how it was determined):
(4) Proposed maximum aggregate value of transaction:
(5) Total fee paid:
Fee paid previously with preliminary materials.
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
(1) Amount Previously Paid:
(2) Form, Schedule or Registration Statement No.:
(3) Filing Party:
(4) Date Filed:
 

*** Exercise Your Right to Vote ***

Important Notice Regarding the Availability of Proxy Materials for the
Shareholder Meeting to Be Held on December 8, 2017.

 

 

MEDTRONIC PLC

 

 

MEDTRONIC PLC

ATTN: RHONDA INGALSBE

710 MEDTRONIC PARKWAY

MS LC300

MINNEAPOLIS, MN 55432-5604

 

 
Meeting Information
 
Meeting Type: Annual General Meeting
For holders as of: October 10, 2017
Date: December 8, 2017     Time: 8:00 AM Local Time
Location: Conrad Dublin Hotel
  Earlsfort Terrace
  Dublin 2, Ireland
   
 
You are receiving this communication because you hold shares in the company named above.
 
This is not a ballot. You cannot use this notice to vote these shares. This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. You may view the proxy materials online at www.proxyvote.com, scan the QR Barcode on the reverse side, or easily request a paper copy (see reverse side).
 
We encourage you to access and review all of the important information contained in the proxy materials before voting.
 
See the reverse side of this notice to obtain proxy materials and voting instructions.
 

Before You Vote

    How to Access the Proxy Materials

 

   
Proxy Materials Available to VIEW or RECEIVE:  
   
NOTICE AND PROXY STATEMENT                          ANNUAL REPORT
 
How to View Online:  
Have the information that is printed in the box marked by the arrow   (located on the following page) and visit: www.proxyvote.com, or scan the QR Barcode below.
 
How to Request and Receive a PAPER or E-MAIL Copy:
If you want to receive a paper or e-mail copy of these documents, you must request one. There is NO charge for requesting a copy. Please choose one of the following methods to make your request:
  1)   BY INTERNET: www.proxyvote.com
  2)   BY TELEPHONE: 1-800-579-1639
  3)   BY E-MAIL*: sendmaterial@proxyvote.com
   
* If requesting materials by e-mail, please send a blank e-mail with the information that is printed in the box marked by the arrow  (located on the following page) in the subject line.
   
Requests, instructions and other inquiries sent to this e-mail address will NOT be forwarded to your investment advisor. Please make the request as instructed above on or before November 26, 2017 to facilitate timely delivery.
         

 

How To Vote
   Please Choose One of the Following Voting Methods
SCAN TO
VIEW MATERIALS & VOTE
W

 

Vote In Person: Many shareholder meetings have attendance requirements including, but not limited to, the possession of an attendance ticket issued by the entity holding the meeting. Please check the meeting materials for any special requirements for meeting attendance.
At the meeting, you will need to request a ballot to vote these shares.
 
Vote By Internet: Go to www.proxyvote.com or from a smart phone, scan the QR Barcode above. Have the information that is printed in the box marked by the arrow  (located on the following page) available and follow the instructions.
 
Vote By Mail: You can vote by mail by requesting a paper copy of the materials, which will include a proxy card.
 
Shareholder Meeting Registration: To vote and/or attend the meeting, go to the “Register for Meeting” link at www.proxyvote.com.
 
 

Voting Items  
 
The Board of Directors recommends you vote FOR the following proposals:
 
1. Election of Directors to serve until the next Annual General Meeting of the Shareholders
     
  Nominees:  
     
  1a. Richard H. Anderson  
       
  1b. Craig Arnold  
       
  1c. Scott C. Donnelly  
       
  1d. Randall Hogan III  
       
  1e. Omar Ishrak  
       
  1f. Shirley A. Jackson, Ph.D.  
       
  1g. Michael O. Leavitt  
       
  1h. James T. Lenehan  
       
  1i. Elizabeth Nabel, M.D.  
       
  1j. Denise M. O’Leary  
       
  1k. Kendall J. Powell  
       
  1l. Robert C. Pozen  
   
2. To ratify, in a non-binding vote, the re-appointment of PricewaterhouseCoopers LLP as Medtronic’s independent auditor for fiscal year 2018 and authorize the Board of Directors, acting through the Audit Committee, to set the auditor’s remuneration.
   
3. To approve in a non-binding advisory vote, named executive officer compensation (a “Say-on-Pay” vote).
   
4. To approve the amendment and restatement of the Medtronic plc Amended and Restated 2013 Stock Award and Incentive Plan.
   
NOTE: In their discretion, the proxy holders are authorized to vote upon such other business as may properly come before the Annual General Meeting and any adjournment or postponement thereof.